author-photo

Timothy Bowler

Regeneron

5

Papers

16

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Outcomes in patients (pts) with advanced basal cell carcinoma (aBCC) who discontinued hedgehog inhibitors (HHI) as first-line (1L) systemic treatment (Tx) in a U.S. community oncology setting: A retrospective observational study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)